About CANF Dividend Returns
Can-Fite BioPharma Ltd. (CANF) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of CANF over the past year?
Can-Fite BioPharma Ltd. (CANF) delivered a return of 169.89% over the past year. Since CANF does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in CANF be worth today?
A $10,000 investment in Can-Fite BioPharma Ltd. one year ago would be worth $26,989 today, representing a gain of $16,989.
Q3Does CANF pay dividends?
Can-Fite BioPharma Ltd. (CANF) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For CANF, the total return equals the price-only return.
Q4Did CANF beat the S&P 500?
Yes, Can-Fite BioPharma Ltd. (CANF) outperformed the S&P 500 by 154.43 percentage points over the past year. CANF delivered a total return of 169.89%, compared to the S&P 500's 15.45%. This 154.43pp alpha means investors in CANF earned more than a passive S&P 500 index fund.
Q5What is CANF's worst drawdown?
Can-Fite BioPharma Ltd. (CANF) experienced a maximum drawdown of -91.58% over the past year, declining from its peak on 2025-03-18 to its trough on 2025-12-29. The stock recovered to its prior peak by 2026-01-05. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is CANF's long-term total return over 10, 20, or 30 years?
Can-Fite BioPharma Ltd. (CANF) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is -98.5% (-34.3% CAGR) — $10,000 would have grown to $150. Over 20 years: -99.4% total return (-22.6% CAGR) — $10,000 → $59. Over 30 years: -99.4% total return (-15.7% CAGR) — $10,000 → $59. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was CANF's best and worst year?
Can-Fite BioPharma Ltd.'s best calendar year was 2013 with a total return of 23.4%. Its worst year was 2025 with a total return of -88.8%. This range shows the volatility investors should expect — the difference between the best and worst year is 112.2 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).